Elizabeth B Takacs1, Karl J Kreder2. 1. Department of Urology, The University of Iowa, 200 Hawkins Dr., 3 RCP, Iowa City, IA, 52242-1089, USA. 2. Department of Urology, The University of Iowa, 200 Hawkins Dr., 3 RCP, Iowa City, IA, 52242-1089, USA. karl-kreder@uiowa.edu.
Abstract
PURPOSE OF REVIEW: Pelvic organ prolapse is a non-life-threatening condition that has a wide variety of symptoms. Sacrocolpopexy has been the "gold standard" for management of apical pelvic organ prolapse with reported high success rates for anatomic correction. Herein, we review the surgical procedure, anatomic, and functional outcomes, as well as the intraoperative and postoperative complications. RECENT FINDINGS: Findings suggest that the ASC has an acceptably low overall complication rate comparable between open and minimally invasive approach. Mesh extrusion and anatomic failure have been shown to increase over time. Patient education and counseling are important preoperatively. It is important to discuss with the patient risks of the surgical procedure, specifically mesh-related extrusion, longer term anatomic recurrence rates, rates of functional improvement, or worsening of bladder and bowel symptoms, as well as rates of dyspareunia.
PURPOSE OF REVIEW: Pelvic organ prolapse is a non-life-threatening condition that has a wide variety of symptoms. Sacrocolpopexy has been the "gold standard" for management of apical pelvic organ prolapse with reported high success rates for anatomic correction. Herein, we review the surgical procedure, anatomic, and functional outcomes, as well as the intraoperative and postoperative complications. RECENT FINDINGS: Findings suggest that the ASC has an acceptably low overall complication rate comparable between open and minimally invasive approach. Mesh extrusion and anatomic failure have been shown to increase over time. Patient education and counseling are important preoperatively. It is important to discuss with the patient risks of the surgical procedure, specifically mesh-related extrusion, longer term anatomic recurrence rates, rates of functional improvement, or worsening of bladder and bowel symptoms, as well as rates of dyspareunia.
Entities:
Keywords:
Dyspareunia; Pelvic organ prolapse; Sacrocolpopexy; Voiding dysfunction
Authors: A G Visco; A C Weidner; M D Barber; E R Myers; G W Cundiff; R C Bump; W A Addison Journal: Am J Obstet Gynecol Date: 2001-02 Impact factor: 8.661
Authors: W F Stewart; J N Liberman; R S Sandler; M S Woods; A Stemhagen; E Chee; R B Lipton; C E Farup Journal: Am J Gastroenterol Date: 1999-12 Impact factor: 10.864
Authors: Susan B Tate; Linda Blackwell; Douglas J Lorenz; Margaret M Steptoe; Patrick J Culligan Journal: Int Urogynecol J Date: 2010-08-27 Impact factor: 2.894
Authors: Geoffrey W Cundiff; Edward Varner; Anthony G Visco; Halina M Zyczynski; Charles W Nager; Peggy A Norton; Joseph Schaffer; Morton B Brown; Linda Brubaker Journal: Am J Obstet Gynecol Date: 2008-10-31 Impact factor: 8.661
Authors: Laura C Skoczylas; Lindsay C Turner; Li Wang; Daniel G Winger; Jonathan P Shepherd Journal: Int Urogynecol J Date: 2013-10-01 Impact factor: 2.894
Authors: Giuseppe Campagna; Luigi Pedone Anchora; Giovanni Panico; Daniela Caramazza; Martina Arcieri; Mauro Cervigni; Giovanni Scambia; Alfredo Ercoli Journal: Int Urogynecol J Date: 2019-12-05 Impact factor: 2.894
Authors: Elliot K Blau; Sarah A Adelstein; Katherine A Amin; Sharon J Durfy; Alvaro Lucioni; Kathleen C Kobashi; Una J Lee Journal: Investig Clin Urol Date: 2019-11-15